TY - JOUR
T1 - Temporal changes in diabetes prevalence and achievement of care goals in urban South Asia from 2010 to 2016 – The Center for Cardio-metabolic Risk Reduction in South Asia Study
AU - Anjana, Ranjit Mohan
AU - Deepa, Mohan
AU - Subashini, Radhakrishnan
AU - Patel, Shivani A.
AU - Kondal, Dimple
AU - Unnikrishnan, Ranjit
AU - Tandon, Nikhil
AU - Prabhakaran, Dorairaj
AU - Venkat Narayan, K. M.
AU - Kadir, Muhammad M.
AU - Mohan, Viswanathan
AU - Ali, Mohammed K.
N1 - Funding Information:
This study is coordinated by CoE‐CARRS (Center of Excellence – Center for cArdio‐metabolic Risk Reduction in South Asia) based at Public Health Foundation of India (PHFI), New Delhi, India in collaboration with Centre for Chronic Disease Control (CCDC), New Delhi, Emory University, Atlanta, U.S.A, All India Institute of Medical Sciences (AIIMS), New Delhi, Madras Diabetes Research Foundation (MDRF), Chennai, India and Aga Khan University, Karachi, Pakistan. We hereby, acknowledge the contributions of the field and research staff of the ‘‘CARRS Surveillance Investigators’ Group’’. This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA. Several members of the research team at PHFI, Emory University and CCDC were/are supported by the Fogarty International Clinical Research Scholars‐Fellows programme (FICRS‐F) through Grant Number 5R24TW007988 from NIH Fogarty International Center (FIC) through Vanderbilt University; D43 NCDs in India Training Program through Award Number D43HD05249 and D43 TW009135 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and FIC; and Wellcome Trust (grant number 096735/A/11/Z). However, the contents of this paper are solely the responsibility of the writing group and do not necessarily represent the official views of FIC, Vanderbilt University, Emory University, PHFI, NICHD, or the NIH.
Funding Information:
The CARRS-I and CARRS-II studies were supported by National Heart, Lung, and Blood Institute of the NIH, Department of Health and Human Services (Contract No. HHSN268200900026C) and United Health Group (Minneapolis, MN, USA). This study is coordinated by CoE-CARRS (Center of Excellence – Center for cArdio-metabolic Risk Reduction in South Asia) based at Public Health Foundation of India (PHFI), New Delhi, India in collaboration with Centre for Chronic Disease Control (CCDC), New Delhi, Emory University, Atlanta, U.S.A, All India Institute of Medical Sciences (AIIMS), New Delhi, Madras Diabetes Research Foundation (MDRF), Chennai, India and Aga Khan University, Karachi, Pakistan. We hereby, acknowledge the contributions of the field and research staff of the ‘‘CARRS Surveillance Investigators’ Group’’. This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA. Several members of the research team at PHFI, Emory University and CCDC were/are supported by the Fogarty International Clinical Research Scholars-Fellows programme (FICRS-F) through Grant Number 5R24TW007988 from NIH Fogarty International Center (FIC) through Vanderbilt University; D43 NCDs in India Training Program through Award Number D43HD05249 and D43 TW009135 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and FIC; and Wellcome Trust (grant number 096735/A/11/Z). However, the contents of this paper are solely the responsibility of the writing group and do not necessarily represent the official views of FIC, Vanderbilt University, Emory University, PHFI, NICHD, or the NIH.
Publisher Copyright:
© 2020 Diabetes UK
PY - 2021/2
Y1 - 2021/2
N2 - Aim: Achievement of treatment targets among individuals with diabetes remains suboptimal in many parts of the globe. We aimed to assess changes in diabetes prevalence and achievement of diabetes care goals in South Asia using two consecutive cross-sectional population-based surveys. Methods: Two representative samples of South Asian adults were recruited using identical methods from Chennai, Delhi, and Karachi in 2010-11 (n = 16,288; response rate–94.7%) and 2015-16 (n = 14,587; response rate–94.0%) through the Center for Cardio-metabolic Risk Reduction in South Asia (CARRS) Study. Quality of care goals were defined as HbA1c <53 mmol/mol (7.0%), blood pressure (BP) control: <140/90 mmHg, lipid control: LDL cholesterol <2.56 mmol/l (100 mg/dl), and self-reported non-smoking. Results: Weighted prevalence of self-reported diabetes increased by 9.0% [13% (95%CI: 13–14) to 15% (14–15)] while that of newly diagnosed diabetes decreased by 16% [6.1% (5.7–6.6) to 5.1% (4.6–5.6)]. There were improvements in achieving glycaemic (25% to 30%, p = 0.002) and lipid (34% to 45%, p < 0.001) goals, but no notable improvements in BP control or smoking status. The proportion of individuals with self-reported diabetes meeting more than one target also increased. Conclusions: Diabetes prevalence continues to grow among urban South Asians and large gaps still exist in the attainment of treatment targets. Concerted policy, systemic, clinical and individual efforts are needed to close these care gaps.
AB - Aim: Achievement of treatment targets among individuals with diabetes remains suboptimal in many parts of the globe. We aimed to assess changes in diabetes prevalence and achievement of diabetes care goals in South Asia using two consecutive cross-sectional population-based surveys. Methods: Two representative samples of South Asian adults were recruited using identical methods from Chennai, Delhi, and Karachi in 2010-11 (n = 16,288; response rate–94.7%) and 2015-16 (n = 14,587; response rate–94.0%) through the Center for Cardio-metabolic Risk Reduction in South Asia (CARRS) Study. Quality of care goals were defined as HbA1c <53 mmol/mol (7.0%), blood pressure (BP) control: <140/90 mmHg, lipid control: LDL cholesterol <2.56 mmol/l (100 mg/dl), and self-reported non-smoking. Results: Weighted prevalence of self-reported diabetes increased by 9.0% [13% (95%CI: 13–14) to 15% (14–15)] while that of newly diagnosed diabetes decreased by 16% [6.1% (5.7–6.6) to 5.1% (4.6–5.6)]. There were improvements in achieving glycaemic (25% to 30%, p = 0.002) and lipid (34% to 45%, p < 0.001) goals, but no notable improvements in BP control or smoking status. The proportion of individuals with self-reported diabetes meeting more than one target also increased. Conclusions: Diabetes prevalence continues to grow among urban South Asians and large gaps still exist in the attainment of treatment targets. Concerted policy, systemic, clinical and individual efforts are needed to close these care gaps.
KW - Adult onset Diabetes
KW - Asian
KW - glycaemic target
KW - quality of care
KW - urban
UR - http://www.scopus.com/inward/record.url?scp=85096695108&partnerID=8YFLogxK
U2 - 10.1111/dme.14424
DO - 10.1111/dme.14424
M3 - Article
C2 - 33067811
AN - SCOPUS:85096695108
SN - 0742-3071
VL - 38
JO - Diabetic Medicine
JF - Diabetic Medicine
IS - 2
M1 - e14424
ER -